Hematopoietic Efficacy of Recombinant Human Erythropoietin (DWP413)
![]() |
최현주
(주)대웅제약 생명과학연구소)
김점용 (주)대웅제약 생명과학연구소) 임승욱 (주)대웅제약 생명과학연구소) 연제덕 (주)대웅제약 생명과학연구소) 고여욱 (주)대웅제약 생명과학연구소) |
1 | Anagnostou, A. (1985). Erythropoietin: a hematopoietic hormone produced by the kidney. Semin. Nephrol. S, 104-114 |
2 | Edward A., Levine, M.D., Arthur L., Rosen, Ph. D., Laksman R., Sehgal, Ph. D., Steven A., Gould, M.D., Joan C., Eglie, Ph. D., Ransa L., Sehgal, B.S.M.T., and Gerald S.Moss. M.D. (1989). Treatment of acute postoperative anemia with recombinant human erythropoietin. J.Trauma, 29, 1134-1139 DOI |
3 | Masunaga, H., Goto, M. and Ueda, M. (1986). Effects of purified erythropoietin in partially nephrectomized rats. Acta Hematol. Jpn. 49, 807-815 |
4 | Masunaga, H., Takahira, Rand Sawai, T. (1991). Effects of recombinant human erythropoietin on renal anemic rats induced by drugs. Folia. Pharmacol. Jpn. 98, 151-160 DOI ScienceOn |
5 | McGonigle R. J., Brookins J, Pegram B. L. Fisher J.W (1987) : Enhanced erythropoietin production by calcium entry blockers in rats exposed to hypoxia. J. Pharmacol. Exp. Then 241, 428-432 |
6 | Fuchs, A. and Eder, H. (1992). Dose dependenl effects of recombinant human erythropoietin on tile reticulocyte population of rabbits. Arzeim.-Forsch./Drug. Res. 42. 10, 1266-1268 |
7 | Vaziri N. D., ZhoLl X. J., and Liao S. Y. (1994). Erythropoietin enhances recorvery from cisplatin-induccd acute renal failure. Am. J. Physiol. 266(Renal Fluid Electrolyte Physiol 35): F360-F366 DOI |
8 | Wood, P. A. and Hrushesky, W. J. M. (1995). Cisplatinassociated anemia; an erythropoietin deficiency syndrome. J. Clin. Invest. Inc. 95, 1650-1659 DOI ScienceOn |
9 | Emest B., Marshall A.L., Barry S.C., Thoman J.K. (ed.)(1995). Williams Hematology pp.704-708. McGraw-Hill, New York |
10 | Jacobs, K, Shoemaker, C., Rudersdorf, R., Neill, S. D., Kaufman, R. J, Mufson, A, Seelu'a, J., jones, S. S., Hewick, R, Fritsch, E. E, Kawakita, M., Shimizu, T and Miyake, T. (1985). Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313, 806-810. DOI ScienceOn |
11 | Kuzur M. E. and Greco F. A. (1980). Cisplatin induced anemia. New Engl. J. Med. 303, 110-112 |
12 | Joseph, W E. and John, W A (1989). Guideline for recombinant human erythropoietin therapy. Am. J. Kidney Dis. 2, 2-8 |
13 | Kim D., H., Ahn B. O., Park J. H., Lee S. H., and Kim W. B. (1998). Efficacy of recombinant human erythropoietin (rhuEPO). J. Appl. Pharmacol. 6,312-316 |
14 | Kim S. J., Ha B. J, Lee D. E., Oh M. S., Kim D. H., Park K. H. and Kim H. S. (1994). Efficacy of recombinant erythropoietin from CHO cells. J. Appl. Phamiacol. 2, 343-346 |
15 | Landschulz K. T., Boyer S. H., Noyes A. n, Rogers O. C, and Frelin L. P. (1992). Onset of erythropoietin response in murine erythroid colony forming units: assignment to early S-phasc in a specific cell generation. Blood, 79, 2749-2758 |
16 | Levine E. A, Rosen A. L., Sehgal L. R., Gould S. A, Egrie j. C, Sehgal H. L and Moss G. S. (1989). Treatment of acute postoperative anemia with recombinant human erythropoietin, J. Trauma 29, 1134-1139 DOI |
17 | Nam C. J., Kim H., Huh J. W, Kang J. K. (1989). Efficacy of recombinant human erythropoietin. Korean J. of the Lab. Anim. Sci. 14, 241-249 |
18 | Nathan D. G., Syikowski A. (1983). Erythropoietin nd the regulation of erythropoiesis. N Engl. J. Med. 306, 520-522 |
19 | Palmeri S., Russo A., Gebbia V, Borsellino N., Gebbia N., Rustum Y., Rausa L. (1990). A phase I-II study on the toxicity and therapeutic efficacy of 5-fluorouracil in cornbinatjion with leucovorin and cisplatin in patients with advanced colorectal carcinoma. J. Chemotherapy suppl. I, 28-32 |
20 | Ridley, D. M., Dawkins, F. and perlin, E. (1994). Erythropoietin : A review. J. Natl. Med. Assoc. 86, 129-135 |
21 | Rothmann, S. A., Paul P., Weick, J. K., Mclntyre, W. R. and Fantelli. F. (1985). Effects of cis-diamminedichloroplatinum on erythropoietin production and hematopoietic progenitor cells. Int. J. Cell Cloning 3, 415-423 DOI ScienceOn |
22 | Roberta L. Scipioni, Richard W. Diters, William R. Myers, and Susan M. Hart. Clinical and clinicopathological assessment of serial phlebotomy in the Sprague Dawley rat. Laboratory Ani. Sci. 1997. 47, 293-299 |
23 | Rossof, A. H., Slayton, R. E. and Pcrlia, C. P. (1972). Preliminary clinical experience with cisdiamminedichloroplatinum (II). Cancer 30, 1451-1450 DOI ScienceOn |
24 | Rathmann S. A. and Wcik J. K. (1981). Cisplatin-induced anemia. New. Eng. J. Med. 303, 110-112. |
25 | Tsuda, E., Goto, M., murakarni, A, Akai, K., Ueda, M., Kawanishi, G., Takakashi, N., Sasaki, R., Chiba, H., ishihara, H., Mori, M., Tejima, S., Endo, S. and Arata, Y. (1988). Comparative structural study of N-linked oligosaccharides of urinary and recombinant eryihropoietins. Biochemistry 27, 5646-5654 DOI ScienceOn |
![]() |